AI-based New Drug Development
- 13:30~17:00
- Bio-Convergence Technology
- Session 1. AI-Driven Drug Development: A Journey Towards Viable Solutions
-
Rm.401
Open Innovation - Pharmaceuticals
- 09:30~11:40
- Business & Development
- Session 4. The Key to Innovation: Global Open Innovation Strategy
-
Rm.401
Anti-aging and Rejuvenation
- 09:30~12:00
- Innovative Biotechnology
- Session 10. Innovative Aging Control Technologies: Immunity, Diagnostics, and Evaluation Platforms
-
Rm.401
Anti-aging and Rejuvenation
- 13:30~15:30
- Innovative Biotechnology
- Session 11. The Present and Future of Reverse-aging Technologies
-
Rm.401
Bio-Digital Convergence Technology
- 13:00~16:00
- Bio-Convergence Technology
- Session 13. Beyond Innovation: The Path to Successful Clinical Adoption and Market Expansion of Digital Therapy
-
Rm.307
Preclinical - Alternative Toxicology Solutions
- 09:30~15:35
- Innovative Biotechnology
- Session 14. Alternative Toxicity Testing: Our Choice and Challenges for Leading the Future Bio Market
-
Rm.308